# Nuvectis Pharma, Inc.: Form 10-K/A for the period ended Dec 31, 2022

- Company: [Nuvectis Pharma, Inc.](/companies/nvct.md) (CIK 1875558)
- Form: 10-K/A
- Filed: 2023-03-27
- Accepted by EDGAR: Mar 27, 2023, 08:31 ET
- Period: 2022-12-31
- Accession: 0001104659-23-036896
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1875558/000110465923036896/tm2310472d1_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1875558/000110465923036896/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1875558/000110465923036896/tm2310472d1_10ka.htm

Filed Mar 27, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-036896. Last ingested by Listed: Nov 4, 2026, 08:08 ET. No prices; not investment advice.